Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19
- PMID: 34553511
- PMCID: PMC7753559
- DOI: 10.1002/hep4.1650
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19
Abstract
Coronavirus disease 2019 (COVID-19) is associated with adverse outcomes, including need for invasive mechanical ventilation and death in people with risk factors. Liver enzyme elevation is commonly seen in this group, but its clinical significance remains elusive. In this study, we calculated the Fibrosis-4 (FIB-4) score for a cohort of hospitalized patients with COVID-19 and assessed its association with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA, inflammatory cytokine levels, and clinical outcome. A total of 202 hospitalized participants who tested positive for SARS-CoV-2 by nasopharyngeal sampling were included in this analysis. FIB-4 was calculated for each participant using the alanine aminotransferase, aspartate aminotransferase, age, and platelet count. We evaluated the association between FIB-4 and mortality using both multivariate logistic regression and Cox proportional hazards model. Correlations between FIB-4 and SARS-CoV-2 RNA and cytokine levels were evaluated using the Spearman test. Among the 202 participants, 22 died. The median FIB-4 in participants who survived and died were 1.91 and 3.98 (P < 0.001 by Mann-Whitney U test), respectively. Each one-unit increment in FIB-4 was associated with an increased odds of death (odds ratio, 1.79; 95% confidence interval, 1.36, 2.35; P < 0.001) after adjusting for baseline characteristics including sex, body mass index, hypertension, diabetes, and history of liver diseases. During hospitalization, FIB-4 peaked and then normalized in the survival group but failed to normalize in the death group. FIB-4 was positively correlated with the level of SARS-CoV-2 viral load and monocyte-associated cytokines, especially interleukin-6 and interferon gamma-induced protein 10. Conclusion: FIB-4 is associated with mortality in COVID-19, independent of underlying conditions including liver diseases. FIB-4 may be a simple and inexpensive approach to risk-stratify individuals with COVID-19.
© 2020 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
Figures
Similar articles
-
Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.Clin Infect Dis. 2021 Aug 2;73(3):e594-e601. doi: 10.1093/cid/ciaa1710. Clin Infect Dis. 2021. PMID: 33909004 Free PMC article.
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
The mortality of hospitalized patients with COVID-19 and non-cirrhotic chronic liver disease: a retrospective multi-center study.PeerJ. 2023 Dec 4;11:e16582. doi: 10.7717/peerj.16582. eCollection 2023. PeerJ. 2023. PMID: 38077441 Free PMC article.
-
Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.J Transl Autoimmun. 2021;4:100083. doi: 10.1016/j.jtauto.2021.100083. Epub 2021 Jan 6. J Transl Autoimmun. 2021. PMID: 33521616 Free PMC article. Review.
-
Liver Fibrosis Scores and Hospitalization, Mechanical Ventilation, Severity, and Death in Patients with COVID-19: A Systematic Review and Dose-Response Meta-Analysis.Can J Gastroenterol Hepatol. 2022 Mar 29;2022:7235860. doi: 10.1155/2022/7235860. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 35369116 Free PMC article. Review.
Cited by
-
Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study.Viruses. 2024 Sep 27;16(10):1530. doi: 10.3390/v16101530. Viruses. 2024. PMID: 39459864 Free PMC article.
-
An Increase in Aspartate Aminotransferase Can Predict Worsening Disease Severity in Japanese Patients with COVID-19.Clin Pract. 2024 Aug 20;14(4):1601-1614. doi: 10.3390/clinpract14040129. Clin Pract. 2024. PMID: 39194933 Free PMC article.
-
Prognostic impact of FAN score in patients receiving nivolumab plus ipilimumab for metastatic renal cell carcinoma.Sci Rep. 2024 May 29;14(1):12398. doi: 10.1038/s41598-024-63403-2. Sci Rep. 2024. PMID: 38811687 Free PMC article.
-
Prognostic Value of Fibrosis 4 (FIB-4) Index in Sepsis Patients.J Pers Med. 2024 May 16;14(5):531. doi: 10.3390/jpm14050531. J Pers Med. 2024. PMID: 38793113 Free PMC article.
-
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy.PLoS One. 2024 May 7;19(5):e0296495. doi: 10.1371/journal.pone.0296495. eCollection 2024. PLoS One. 2024. PMID: 38713731 Free PMC article.
References
-
- COVID‐19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. 2020. https://publichealthupdate.com/jhu/. Accessed 30 November, 2020.
-
- Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID‐19): a review. JAMA 2020;324:782‐793. - PubMed
-
- Ali N, Hossain K. Liver injury in severe COVID‐19 infection: current insights and challenges. Expert Rev Gastroenterol Hepatol 2020;14:879‐884. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous